Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses

被引:148
作者
O'Connor, DH
Mothe, BR
Weinfurter, JT
Fuenger, S
Rehrauer, WM
Jing, PC
Rudersdorf, RR
Liebl, ME
Krebs, K
Vasquez, J
Dodds, E
Loffredo, J
Martin, S
McDermott, AB
Allen, TM
Wang, CX
Doxiadis, GG
Montefiori, DC
Hughes, A
Burton, DR
Allison, DB
Wolinsky, SM
Bontrop, R
Picker, LJ
Watkins, DI
机构
[1] Dept Pathol, Madison, WI 53706 USA
[2] Wisconsin Reg Primate Res Ctr, Madison, WI 53706 USA
[3] Lab Med, Madison, WI 53706 USA
[4] Univ Alabama, Birmingham, AL USA
[5] Duke Univ, Dept Expt Surg, Durham, NC USA
[6] Univ S Carolina, Columbia, SC 29208 USA
[7] Scripps Res Inst, La Jolla, CA USA
[8] Northwestern Univ, Sch Med, Chicago, IL USA
[9] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR USA
[10] TNO, Biomed Primate Res Ctr, Rijswijk, Netherlands
关键词
D O I
10.1128/JVI.77.16.9029-9040.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Certain major histocompatibility complex class I (MHC-I) alleles are associated with delayed disease progression in individuals infected with human immunodeficiency virus (HIV) and in macaques infected with simian immunodeficiency virus (SIV). However, little is known about the influence of these MHC alleles on acute-phase cellular immune responses. Here we follow 51 animals infected with SIV(mac)239 and demonstrate a dramatic association between Mamu-A*01 and -B*17 expression and slowed disease progression. We show that the dominant acute-phase cytotoxic T lymphocyte (CTL) responses in animals expressing these alleles are largely directed against two epitopes restricted by Mamu-A*01 and one epitope restricted by Mamu-B*17. One Mamu-A*01-restricted response (Tat(28-35)SL8) and the Mamu-B*17-restricted response (Nef(165-173)IW9) typically select for viral escape variants in early SIV a 239 infection. Interestingly, animals expressing Mamu-A*1 and -B*17 have less variation in the Tat(28-35)SL8 epitope during chronic infection than animals that express only Mamu-A*01. Our results show that MHC-I alleles that are associated with slow progression to AIDS bind epitopes recognized by dominant CTL responses during acute infection and underscore the importance of understanding CTL responses during primary HIV infection.
引用
收藏
页码:9029 / 9040
页数:12
相关论文
共 70 条
[1]   Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication [J].
Allen, TM ;
Mortara, L ;
Mothé, BR ;
Liebl, M ;
Jing, PC ;
Calore, B ;
Piekarczyk, M ;
Ruddersdorf, R ;
O'Connor, DH ;
Wang, X ;
Wang, CX ;
Allison, DB ;
Altman, JD ;
Sette, A ;
Desrosiers, RC ;
Sutter, G ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4108-4112
[2]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[3]  
Allen TM, 1998, J IMMUNOL, V160, P6062
[4]   Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection [J].
Allen, TM ;
Jing, PC ;
Calore, B ;
Horton, H ;
O'Connor, DH ;
Hanke, T ;
Piekarczyk, M ;
Ruddersdorf, R ;
Mothé, BR ;
Emerson, C ;
Wilson, N ;
Lifson, JD ;
Belyakov, IM ;
Berzofsky, JA ;
Wang, CX ;
Allison, DB ;
Montefiori, DC ;
Desrosiers, RC ;
Wolinsky, S ;
Kunstman, KJ ;
Altman, JD ;
Sette, A ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (20) :10507-10511
[5]  
Balla-Jhagjhoorsingh SS, 1999, J IMMUNOL, V162, P2308
[6]   Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].
Barouch, DH ;
Kunstman, J ;
Kuroda, MJ ;
Schmitz, JE ;
Santra, S ;
Peyerl, FW ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Gorgone, DA ;
Montefiori, DC ;
Lewis, MG ;
Wolinsky, SM ;
Letvin, NL .
NATURE, 2002, 415 (6869) :335-339
[7]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[8]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[9]   Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef [J].
Evans, DT ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Sidney, J ;
da Silva, J ;
Allen, TM ;
Horton, H ;
Venham, JE ;
Rudersdorf, RA ;
Vogel, T ;
Pauza, CD ;
Bontrop, RE ;
DeMars, R ;
Sette, A ;
Hughes, AL ;
Watkins, DI .
NATURE MEDICINE, 1999, 5 (11) :1270-1276
[10]   Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression [J].
Gange, SJ ;
Mellors, JW ;
Lau, B ;
Detels, R ;
Phair, JP ;
Muñoz, A ;
Margolick, JB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (13) :1223-1229